Artificial intelligence is transforming life sciences in the UK, enabling faster decision making, improved data analysis and greater operational efficiency across regulated environments. From automating complex processes to enhancing scientific and quality outcomes, AI offers significant opportunities to improve both effectiveness and performance.
However, in GxP regulated settings, AI adoption must go beyond innovation. It requires structured governance, clear policy frameworks and a risk based approach to validation to ensure full AI compliance with regulatory expectations. Without this, organisations risk compliance gaps, data integrity issues and increased regulatory scrutiny.
At IS Compliance Solutions, we support organisations in implementing AI in life sciences in a controlled, compliant and scalable way. Our approach aligns AI initiatives with GxP requirements, regulatory guidance and business objectives, ensuring solutions are both effective and audit ready.
We focus on embedding AI within existing quality management systems, supporting validation, data integrity and lifecycle control. This ensures AI solutions deliver measurable efficiency gains while remaining fully compliant, transparent and inspection ready across the organisation.
Expectation is that AI systems used in the development, manufacture or monitoring of medicines and medical devices to comply with existing GxP standards.
USA FDA
The FDA has made clear that AI/ML-based systems, including Software as a Medical Device (SaMD), are subject to the same regulatory controls as other medical technologies.
EU EMA
Edit your Features from the Pages tab bThe European Medicines Agency expects AI to operate within established GxP frameworks, including GMP, GVP and GCP.y clicking the edit button.
EU
The EU AI Act introduces a risk-based framework for AI systems, with many life sciences applications likely to be classified as high-risk.
AI systems are not recognised as decision-makers. Responsibility for outcomes remains fully with the regulated entity.
Data Integrity
Inputs, transformations, and outputs generated by AI systems must remain attributable, traceable, and reviewable.
Validation
AI does not sit outside established validation principles. However, defining appropriate validation approaches for adaptive or non-deterministic systems presents new challenges.
Human in the Loop
Regulators continue to expect meaningful human control over GxP-relevant decisions.
Ready to move forward with AI in a controlled, compliant and scalable way?
We support organisations across governance, validation and regulatory readiness.
Take the next step on your AI Journey and book a consultation or contact us today to start with the confidence we are by your side.